Ian Read

Ian C.
Read is the founder of Population Health Investment Co., Inc., founded in 2020, where the title held is Executive Chairman.
Current jobs include Vice Chairman at The Kennedy Center Corporate Fund; Director at International Federation of Pharmaceutical Manufacturers, Catalyst, Inc., Saama Technologies, Inc. (since 2021), Pharmaceutical Research & Manufacturers of America (since 2010), Healthcare Leadership Council, United States Council for International Business, The Council on Competitiveness, US-China Business Council (since 2015), European Federation of Pharmaceutical Industries & Assns, Empery Digital, Inc. (since 2025), TriNetX, LLC (since 2021); Member of President's Export Council; Operating Partner at The Carlyle Group, Inc. (California) since 2020; and Member-Supervisory Board at avateramedical NV since 2020.
Former jobs include Chief Executive Officer at Pfizer Brasil Ltda.
from 1992 to 1995; Executive Chairman at Pfizer Inc. in 2019; Chairman at DXC Technology Co. from 2020 to 2022; Chairman at Areteia Therapeutics, Inc. from 2022 to 2025; Director at Kimberly-Clark Corp.
from 2007 to 2011; Director at Curia Global, Inc.; Director at The Partnership for New York City, Inc.; Director at Viatris, Inc. from 2020 to 2022; Member-Supervisory Board at DSM BV; President at Zoetis, Inc.; Executive Vice President-Europe & Canada at PF Consumer Healthcare Canada ULC from 2000 to 2001; Executive Vice President at Pfizer Pharmaceuticals, Inc.; and Chief Financial Officer at Pfizer SA de CV.
Education includes an undergraduate degree from Imperial College London, conferred in 1974.